Find in Library
Search millions of books, articles, and more
Indexed Open Access Databases
Eukaryotic elongation factor 2 kinase is a potential new target for the treatment of tumors
oleh: LI Yang, ZHU Lei
Format: | Article |
---|---|
Diterbitkan: | Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2024-07-01 |
Deskripsi
Eukaryotic elongation factor 2 kinase (eEF2K) is a Ca2+/ CAM-dependent protein kinase, which inhibits the activity of substrate eEF2 by phosphorylating eEF2 to prevent protein synthesis, promote tumor cell proliferation, invasion, metastasis and to regulate tumor microenvironment. The eEF2K is “α-kinase” member of the atypical protein kinase family and has little sequence homology with typical protein kinases. Targeting eEF2K can avoid the toxic side effects caused by most kinases, so it is considered as a potential molecular target for tumor targeted therapy.